Supplementary Table S2 from Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance
收藏NIAID Data Ecosystem2026-05-17 收录
数据链接：
官方服务：
资源简介：
Summary of data from target efficacy evaluation
创建时间：
2017-11-01
